Welcome to the EPA 2021 Interactive Programme
The viewing of sessions and E-Posters cannot be accessed from this conference calendar. All sessions and E-Posters are accessible via the Main Lobby in the virtual platform.
The congress will officially run on Central European Summer Time (CEST)
To convert the congress times to your local time Click Here
Fully Live with Live Q&A On Demand with Live Q&A ECP Session Section Session EPA Course (Pre-Registration Required) Product Theatre
Sessions with Voting Ask the Expert Live TV
The symposium aims to address the broad-spectrum treatment of schizophrenia using the clinical staging framework. In the first lecture the role of partial dopamine agonists in the first episode of psychosis will be uncovered utilizing cariprazine, a third-generation antipsychotic medication as an example. Then, the second lecture will focus on the three R’s in the middle stage of schizophrenia: relapse, remission and recovery, and explain how cariprazine data from clinical trials are linked to these concepts. The final lecture will detail the treatment goals and options in the chronic stage of schizophrenia with special attention to the neurocognitive and negative symptoms and their connection to quality of life and everyday functioning.